Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
about
Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous diseaseVoriconazole monitoring in children with invasive fungal infectionsAchieving target voriconazole concentrations more accurately in children and adolescents.In vitro study of the variable effects of proton pump inhibitors on voriconazoleTherapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole.Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.Safety, Efficacy, and Exposure-Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis.Comparison of clinical pharmacology of voriconazole and posaconazole.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients--an evidence-based approach.Therapeutic drug monitoring of anti-infective agents in critically ill patients.Pharmacokinetic considerations in treating invasive pediatric fungal infections.Optimization of anti-infective dosing regimens during online haemodiafiltrationPharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.Antifungal stewardship considerations for adults and pediatrics.An Optimized Voriconazole Dosing Strategy to Achieve Therapeutic Serum Concentrations in Children Younger than 2 Years Old.Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre.Utility of voriconazole therapeutic drug monitoring: a meta-analysis.Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections.Autoinduction of voriconazole metabolism in a child with invasive pulmonary aspergillosis.Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study.Need of voriconazole high dosages, with documented cerebrospinal fluid penetration, for treatment of cerebral aspergillosis in a 6-month-old leukaemic girl.A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States.Vertebral aspergillosis in a patient with autosomal-dominant hyper-IgE syndrome.Aspergillosis in solid organ transplantation.Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis.Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.Voriconazole: Poor Oral Bioavailability and Possible Renal Toxicity in an Infant With Invasive Aspergillosis.Invasive Aspergillosis in Children: Update on Current Guidelines
P2860
Q33555723-F01A8125-1C43-4CD1-9269-1E72B3FA07F4Q35157940-2361F3BD-F9B0-4F7C-9E72-10B65B769DBEQ35607652-8BAB8407-F1D3-4E6B-A09F-FFAD7E04E6C5Q35960842-DED7621C-8CF8-4763-AE7B-E23B7E75B0B1Q36608562-9446769D-8A76-46A2-9AF5-17CF2EE1AF6EQ37688257-23031EFA-03D7-45C9-979B-F05D0D4B3C75Q37693296-AF4FD73F-FB29-4949-80AC-8F5BD5745F71Q37727651-EE918C9E-72E9-473A-B79A-70682E937088Q38193337-53AB43F9-D8CC-49B4-BDDD-ED1D5A2FCF4CQ38362057-F6848536-DF5D-46AD-8FC6-B16C70EA457DQ38790740-484F3227-FA69-48D6-A0CE-F26B4734E004Q38816614-D3BC942A-48B7-4489-B777-A5225C4B4801Q38843412-FF3AB14B-5AF0-4CDC-9290-16E00CA98078Q38880522-2933202E-64BC-4B28-833D-83BB23128957Q38944746-22B40D66-4DA0-4D2B-A3E9-06FDCF4D2AEBQ39466921-513B8634-6436-47BE-BB1D-FC82CD46F84DQ39893350-06E4FFF3-7554-4E16-9799-DFDD4CE14EA5Q40679884-0C1EB41F-B1BF-4C2D-BE9D-CBB48B383B12Q40842732-33B580CD-A6C2-4B6B-89BA-F024B552EE03Q40913870-7288FE38-27EC-4FBD-A550-AA5DCA5ABD37Q41057395-44E792FA-9191-459A-A01F-C56A8C7A52AFQ41284722-2DC0CD3C-E10B-40C0-8626-DE5F98FF25DCQ41444763-390A12F4-27F2-4111-88B8-14071A8D8B74Q41564706-6D65BEDD-9980-47DA-9070-268546A12E0DQ41907785-CCCA2EF6-162D-4E7B-BA37-241DB030761AQ42272291-99E09644-7B1B-460B-9EC4-75CDEAC02EF7Q45158220-09C02DDF-4FF2-4E97-8158-580FC364595FQ47781187-6C5E8B89-18B6-4058-91B3-EA880D97D2CAQ50325686-40BA8A80-B2E6-42A9-8E1C-461EC0904D8EQ58775551-6A48EE27-79FC-401B-9858-5B436871919E
P2860
Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Voriconazole drug monitoring i ...... children: a prospective study.
@en
Voriconazole drug monitoring i ...... children: a prospective study.
@nl
type
label
Voriconazole drug monitoring i ...... children: a prospective study.
@en
Voriconazole drug monitoring i ...... children: a prospective study.
@nl
prefLabel
Voriconazole drug monitoring i ...... children: a prospective study.
@en
Voriconazole drug monitoring i ...... children: a prospective study.
@nl
P2093
P2860
P50
P356
P1476
Voriconazole drug monitoring i ...... children: a prospective study.
@en
P2093
Concepció Figueras
Eva Roselló
Leonor Pou
Marie Antoinette Frick
P2860
P304
P356
10.1093/JAC/DKR517
P407
P577
2011-12-21T00:00:00Z